Insulin Icodec Showed Comparable Efficacy and Safety- moh bahrain ได้รับการอนุมัติ บริษัท ฆ่าเชื้อโรค ,This material is intended for global medical media only, excl US For journalistic assessment and preparation before publication. Today, Novo Nordisk announced results from a phase 2 clinical trial of investigational insulin icodec, a once-weekly basal insulin analogue.

Copyright ©AoGrand All rights reserved